Im genuinely confused at the share price for the same reasons. Either we are missing something big (legal issue, drug doesnt work, fraud) or this really is one of the golden missed opportunities. Everything is shaping up nicely and as you said this can be a long play or a short play, could sell it for $3 or wait for buyout in the $6 to $30 range.
Ann: Invex Granted Key European Patent for Exenatide, page-46
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.839M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 41290 | 8.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 9000 | 1 |
View Market Depth
| Last trade - 16.21pm 03/07/2025 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable